U.S. market Closed. Opens in 3 hours 2 minutes

RARE | Ultragenyx Pharmaceutical Inc. Stock Financials Income Statements Annual

(Stock Exchange: NASDAQ)
*Sign In to persist settings
Financial Year End2023-12-312022-12-312021-12-312020-12-312019-12-312018-12-312017-12-312016-12-312015-12-312014-12-312013-12-312012-12-312011-12-31
Revenue434.25M363.33M351.41M271.03M103.71M51.49M2.61M133.00KN/AN/AN/AN/AN/A
Cost of Revenue45.21M28.32M16.01M6.13M9.01M1.15M1.00KN/AN/AN/AN/AN/AN/A
Gross Profit389.04M335.01M335.40M264.90M94.71M50.35M2.61MN/AN/AN/AN/AN/AN/A
Operating Expenses958.25M983.93M717.13M595.02M518.88M421.72M331.55M248.14M147.74M56.78MN/AN/AN/A
Selling, General & Admin309.80M278.14M219.98M182.93M161.52M127.72M99.91M64.94M33.00M10.81M4.45M3.34M1.84M
Research & Development648.45M705.79M497.15M412.08M357.36M294.00M231.64M183.20M114.74M45.97M27.83M12.64M4.72M
Other Operating Expenses-337.00K9.51M241.00K7.64M12.45M3.95MN/AN/AN/AN/AN/AN/AN/A
Operating Income-569.21M-648.92M-381.74M-330.12M-424.17M-371.37M-328.94M-248.01M-147.74M-56.78M-32.28M-15.98M-6.56M
Other Expenses / Income-39.26M-52.81M-71.24M144.76M24.73M174.28M10.60M2.17M2.12M-3.02M-2.79M-349.00K-288.00K
Before Tax Income-608.46M-701.73M-452.98M-185.36M-399.44M-197.10M-318.34M-245.84M-145.62M-59.80M-35.07M-16.33M-6.85M
Income Tax Expenses-1.82M5.70M1.04M1.21M3.28M514.00K-16.20M35.00KN/AN/AN/AN/AN/A
Net Income-606.64M-707.42M-454.02M-186.57M-402.73M-197.61M-302.14M-245.87M-145.62M-59.80M-35.07M-16.33M-6.85M
Interest Expenses66.00M43.02M29.42M33.29M1.14MN/AN/AN/AN/AN/AN/AN/A270.00K
Basic Shares Outstanding73.54M69.91M67.80M60.85M56.58M49.78M42.45M39.59M36.78M28.76M3.38M9.94M1.62M
Diluted Shares Outstanding73.54M69.91M67.80M60.85M56.58M49.78M42.45M39.59M36.78M28.76M3.38M9.94M1.62M
EBITDA-516.85M-639.41M-381.50M-322.47M-411.72M-541.70M-312.51M-242.41M-146.35M-56.09M-34.63M-16.02M-6.54M
EBITDA Margin-119.02%-175.99%-108.56%-118.98%-396.98%-1,051.94%-11,964.51%-182,266.92%0.00%0.00%0.00%0.00%0.00%
EBIT-542.46M-658.71M-423.56M-152.07M-398.31M-197.10M-318.34M-245.84M-145.62M-59.80M-35.07M-16.33M-6.58M
EBIT Margin-124.92%-181.30%-120.53%-56.11%-384.05%-382.75%-12,187.52%-184,841.35%0.00%0.00%0.00%0.00%0.00%
Financial Year End2023-12-312022-12-312021-12-312020-12-312019-12-312018-12-312017-12-312016-12-312015-12-312014-12-312013-12-312012-12-312011-12-31
An error has occurred. This application may no longer respond until reloaded. Reload 🗙